| SPIRIT 2013 statement: defining standard protocol items for clinical trials AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ... Annals of internal medicine 158 (3), 200-207, 2013 | 6127 | 2013 |
| SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials AW Chan, JM Tetzlaff, PC Gøtzsche, DG Altman, H Mann, JA Berlin, ... Bmj 346, 2013 | 5084 | 2013 |
| Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical … MJ Moore, D Goldstein, J Hamm, A Figer, JR Hecht, S Gallinger, HJ Au, ... Journal of clinical oncology 25 (15), 1960-1966, 2007 | 4895 | 2007 |
| Regional nodal irradiation in early-stage breast cancer TJ Whelan, IA Olivotto, WR Parulekar, I Ackerman, BH Chua, A Nabid, ... New England Journal of Medicine 373 (4), 307-316, 2015 | 1311 | 2015 |
| Enzalutamide with standard first-line therapy in metastatic prostate cancer ID Davis, AJ Martin, MR Stockler, S Begbie, KN Chi, S Chowdhury, ... New England Journal of Medicine 381 (2), 121-131, 2019 | 1283 | 2019 |
| Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials EL Korn, PY Liu, SJ Lee, JAW Chapman, D Niedzwiecki, VJ Suman, ... Journal of Clinical Oncology 26 (4), 527-534, 2008 | 810 | 2008 |
| Extending aromatase-inhibitor adjuvant therapy to 10 years PE Goss, JN Ingle, KI Pritchard, NJ Robert, H Muss, J Gralow, K Gelmon, ... New England Journal of Medicine 375 (3), 209-219, 2016 | 720 | 2016 |
| Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial P Warde, M Mason, K Ding, P Kirkbride, M Brundage, R Cowan, ... The Lancet 378 (9809), 2104-2111, 2011 | 694 | 2011 |
| Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer W Xie, MM Regan, M Buyse, S Halabi, PW Kantoff, O Sartor, H Soule, ... Journal of Clinical Oncology 35 (27), 3097-3104, 2017 | 411 | 2017 |
| NCIC-CTG MA. 20: an intergroup trial of regional nodal irradiation in early breast cancer. TJ Whelan, I Olivotto, I Ackerman, JW Chapman, B Chua, A Nabid, ... Journal of Clinical Oncology 29 (18_suppl), LBA1003-LBA1003, 2011 | 349 | 2011 |
| Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer … R Gray, R Bradley, J Braybrooke, Z Liu, R Peto, L Davies, D Dodwell, ... The lancet 393 (10179), 1440-1452, 2019 | 345 | 2019 |
| Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial CC Parker, NW Clarke, AD Cook, HG Kynaston, PM Petersen, C Catton, ... The Lancet 396 (10260), 1413-1421, 2020 | 316 | 2020 |
| Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions W Parulekar, G Di Primio, F Matzinger, C Dennie, G Bociek Chest 120 (1), 19-25, 2001 | 307 | 2001 |
| Final report of the intergroup randomized study of combined androgen-deprivation therapy plus radiotherapy versus androgen-deprivation therapy alone in locally advanced … MD Mason, WR Parulekar, MR Sydes, M Brundage, P Kirkbride, ... Journal of Clinical Oncology 33 (19), 2143-2150, 2015 | 296 | 2015 |
| Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate … DS Ernst, IF Tannock, EW Winquist, PM Venner, L Reyno, MJ Moore, ... Journal of Clinical Oncology 21 (17), 3335-3342, 2003 | 294 | 2003 |
| Phase I trial design for solid tumor studies of targeted, non-cytotoxic agents: theory and practice WR Parulekar, EA Eisenhauer Journal of the National Cancer Institute 96 (13), 990-997, 2004 | 268 | 2004 |
| Scoring oral mucositis W Parulekar, R Mackenzie, G Bjarnason, RCK Jordan Oral oncology 34 (1), 63-71, 1998 | 266 | 1998 |
| SPIRIT 2013 Statement: defining standard protocol items for clinical trials AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ... Revista Panamericana de Salud Pública 38, 506-514, 2015 | 263 | 2015 |
| Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled … A Sahgal, SD Myrehaug, S Siva, GL Masucci, PJ Maralani, M Brundage, ... The Lancet Oncology 22 (7), 1023-1033, 2021 | 245 | 2021 |
| Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents PJ Goodwin, V Stambolic, J Lemieux, BE Chen, WR Parulekar, ... Breast cancer research and treatment 126, 215-220, 2011 | 217 | 2011 |
